Chinese Journal of New Drugs 2012 Issue 23 Impact of the intellectual property on the performance of listed companies of pharmaceutical industry

Impact of the intellectual property on the performance of listed companies of pharmaceutical industry
WANG Qing-hua;GUAN Rui;WANG Ling

..............page:2719-2722

WINDOW OF NEW DRUGS

..............page:2705-2708

Bioequivalence of domestic and imported bambuterol tablets in healthy volunteers
SONG Wei;YANG Jing;ZHOU Lun;FENG Zhi-jun;YANG Lin;LU Cheng-tao;SONG Ying;WEN Ai-dong

..............page:2785-2789,2793

Research progress in application of dipeptidyl peptidase-IV inhibitors combined with metformin
HUANG Jian-quan;WANG Guan-chun

..............page:2753-2757

2012 zhong guo sheng wu zhi pin nian hui zuo di shi er ci quan guo sheng wu zhi pin xue shu yan tao hui cheng gong zhao kai

..............page:2698

Preparation and structural determination of tecovirimat monohydrate crystal
DONG Ming-xin;LI Hai-tao;WANG Xiao-hua;MAO Wen-xiang;ZHOU Shang-min;DAI Qiu-yun

..............page:2736-2739

bian zhe tui jian
zhou zhuo

..............page:2700

Simultaneous determination of glycine and cyeteine hydrochloride in compound glycyrrhizin injection by HPLC
XUE Xiao1;WANG Ai-ming2;LIU Ying3;ZHANG Xiao-ling1;YAN Xiao-xiao1; CHANG Xiao-hui1;HE Xia1;WANG Dong-kai1

..............page:2804-2807

Pharmaceutic research progress of benzodiazepines
ZHAO Yan-min1;WANG Zhi-min1;ZHENG Ai-ping2

..............page:2771-2775

Simultaneous determination of 7 components in Danhong injection by HPLC under different UV-vis waves
FU Chan1;2;LUO Juan-min3;WANG Yi-ming1;LIANG Qiong-lin1;LUO Guo-an1

..............page:2817-2820

Consideration of the necessity and feasibility strengthening drug research supervision in China
ZHANG Ke-liang;WEI Jing;SHEN Wen-juan;WANG Li;HU Chun-li

..............page:2731-2735,2739

Standardization of quality assurance audit conducted in GLP facility
WANG Jia-nan;CAO Cai

..............page:2716-2718,2722

ou meng xian zhi zuo mei mo si shi ying zheng wai shi yong

..............page:2803

Advantages of vitamin E TPGS and its P-glycoprotein-inhibiting mechanism
ZHOU Xiao-xing;SONG Shuang-shuang;WANG Dong-kai

..............page:2758-2762

Chemically compatible stability of methotrexate for injection in 4 kinds of infusions
LIU Heng-ge1;HAN Qiang2;WANG Lai-cheng2

..............page:2808-2810,2820

2011 nian quan qiu shang shi de xin yao
liao bin liao qing jiang

..............page:2712-2715

zhi liao zhuan yi xing jia zhuang xian sui yang ai xin yao huo mei pi zhun shang shi

..............page:2807

Advance in the study of the insulin-stimulated PI3K/PKB signal pathway
ZHENG Xiao-ke;WANG Wei-wei;FENG Wei-sheng

..............page:2763-2770

Preparation of tolterodine PLGA micorspheres and its in vitro release properties
LIU Wen-hua1;PAN Zhen-xiang1;LI You-xin2;SUN Feng-ying2

..............page:2821-2825

Toxicity of hyperoside after long-term oral administration in Wistar rats
AI Guo1;2;HUANG Zheng-ming2;WANG De-wen1;ZHANG Hai-ting3

..............page:2811-2816,2828

Preparation and evaluation of berbenine hydrochloride self-microemulsion containing natural emulsifier in vitro and in vivo
HUANG Si-hang;LONG Xiao-ying;YUAN Fei;CHEN Li;ZHANG Miao-hong;CAI Bao-ling;LIU Chang-shun

..............page:2794-2799

Brentuximab vedotin: a new therapeutic agent for Hodgkin lymphoma
LIU Ming-ying1;2;CUI Xiang-li1;ZHAO Zhi-gang1;LIU Sheng-nan1

..............page:2709-2711,2715

Research progress in action mechanisms of mycophenolate mofetil
ZHANG Zhi-lai1;GU Jue-fen2

..............page:2744-2747,2770

Effects of self-assembling modifications on PAMAM-mediated gene delivery in different cell lines
YIN Zhe;HAO Yan-li;LIU Nan;WANG Lan;MA Ming-shu;YAN Dong;ZHANG Xiao-ning

..............page:2740-2743,2752

Anti-tumor effect of triterpene GLE from Ganoderma Lucudum in vivo and in vitro
LIU Feng1;3;LI Peng2;3;HUANG Xiu-wang3;XU Jian-hua1;3

..............page:2790-2793

Patent risk factor analysis of Chinese pharmaceutical enterprises
DONG Li1;HUANG Tai-kang2;YUAN Hong-mei1

..............page:2727-2730

LC-MS/MS determination of 48-h urine excretion rates of ivabradine and N-desmethylivabradine in healthy Chinese volunteers
LU Cheng-tao;CHEN Min-chun;JIA Yan-yan;SONG Ying;YANG Jing; DING Li-kun;LI Xue-qing;ZHOU Lun;WEN Ai-dong

..............page:2780-2784

One case of clindamycin-induced allotriogeusia and analysis of the relevant literature
WEN Xiao-na

..............page:2826-2828

Research advances in pharmacogenetics of chemotherapeutic agents
TIAN Hui1;ZHANG Qi2

..............page:2748-2752

Effect of adding self-emulsifying excipients on release rate of tetramethylpyrazine-release solid dispersion
WANG Li-sheng;CHEN Xiao-dan;Lü Geng-bin;TU Xing;WU Jun-hong

..............page:2800-2803

The laws,regulations and management system for re-evaluation of marketed Chinese patent medicines
LI Bo;GAO Rui;LI Rui;LU Fang;ZI Ming-jie;TANG Xu-dong

..............page:2723-2726

Therapeutic effect of tandospirone on irritable bowel syndrome-diarrhea complicated with anxiety
LAN Ling1;CHEN Yu-long2;CHU Yan-jun2;WANG Jin2;JIA Bai-ling1;TANG Shi-xiao3;XIA Guo-dong3

..............page:2776-2779,2784